SPA4 is a surfactant protein A-derived peptide containing hydrophobic and charged residues that promote membrane and receptor interactions. The sequence helps model innate immune recognition at air-liquid interfaces. Researchers examine its structural transitions, aggregation, and binding to lipids or receptors. Applications include pulmonary-peptide research, host-defense motif analysis, and peptide-based surfactant design.
SPA4 is a synthetic peptide agonist designed to interact specifically with surfactant protein A (SP-A) pathways, making it a valuable tool in immunological and pulmonary research. As a peptide compound, SPA4 mimics or modulates the activity of endogenous SP-A, which is a key regulator in innate immune defense mechanisms within the lung. By targeting SP-A receptors, SPA4 enables researchers to probe the molecular mechanisms underlying host-pathogen interactions, inflammatory responses, and surfactant-mediated signaling. Its well-characterized structure and defined activity profile position it as an important reagent for studies seeking to unravel the complexities of pulmonary immunity and surfactant biology.
Innate Immunity Studies: SPA4 is frequently employed in investigations focused on the modulation of innate immune responses, particularly in the context of pulmonary tissues. By serving as a functional agonist for SP-A pathways, it allows researchers to dissect the downstream effects of SP-A receptor activation, including cytokine release, phagocytosis enhancement, and pathogen clearance. Use of this peptide in in vitro and ex vivo models provides a controlled means to elucidate the specific contributions of SP-A signaling to the first line of defense against respiratory pathogens.
Inflammatory Pathway Elucidation: The peptide is instrumental in exploring the cellular and molecular mechanisms governing inflammation in airway and alveolar environments. By selectively activating SP-A-dependent signaling cascades, SPA4 facilitates the study of inflammatory mediator production, immune cell recruitment, and resolution processes. This application is particularly valuable for distinguishing the roles of surfactant proteins in balancing pro- and anti-inflammatory responses during infection, injury, or allergen exposure.
Receptor-Ligand Interaction Analysis: SPA4 serves as a precise tool for mapping the interaction dynamics between surfactant protein A and its cellular receptors. Through the use of labeled or structurally modified variants, researchers can quantify binding affinities, characterize receptor specificity, and investigate conformational changes upon ligand engagement. Such studies are fundamental for advancing understanding of surfactant protein-receptor biology and for developing new assays targeting these interactions.
Pulmonary Surfactant Research: In studies of surfactant homeostasis and function, SPA4 provides a means to selectively modulate SP-A activity without introducing confounding variables associated with whole protein preparations. The peptide enables detailed analyses of surfactant protein contributions to lipid spreading, surface tension regulation, and alveolar stability. This application is particularly relevant for research into the biophysical and biochemical properties of pulmonary surfactant systems, supporting the development of improved models for lung function and disease.
Peptide-Based Screening Platforms: SPA4 is also utilized in the development and validation of high-throughput screening assays aimed at identifying modulators of SP-A-mediated pathways. By providing a reproducible and well-characterized agonist, it enhances assay reliability and facilitates the discovery of novel compounds or peptides with potential to influence surfactant protein functions. This direction supports the expansion of peptide-based drug discovery and the refinement of screening technologies in respiratory and immunological research.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More